Table of Contents

	Herbal Medicines
		Herbal medicinal products in the European Union
	Current Topics
		Miltefosine registered for visceral leishmaniasis in India
		Tetanus vaccine pre-filled injection device
		Nonoxinol 9 ineffective in preventing HIV infection
		New formula oral rehydration salts
		International AIDS Society recommendations for antiretroviral treatment: adult HIV infection
	Good Clinical Practices
		Development of Chinese good clinical practices (GCP)
	Safety Information
		Statins: rhabdomyolysis and myopathy
		Tamoxifen and risks of thromboembolic events
		Oral contraceptives and risk of cervical cancer
		HIV-associated lipodystrophy syndrome overview
	Regulatory Action
		Alosetron hydrochloride: restricted marketing
		Baclofen: abrupt discontinuation dangerous
		Irinotecan: prescribing changes
		Sodium oxybate/GHB approved for cataplexy
		Rofecoxib: new indication and label changes
	Essential Medicines
		New procedures for updating the Model List of Essential Medicines
		Core list (revised in April 2002)
		WHO Model List of Essential Medicines: Complementary List
	Recent Publications and Sources of Information
		Genomics and world health
		Legal status of traditional and complementary medicine
		Kinetoplastid research source launched
		Endocrine disrupting chemicals
	Proposed International Nonproprietary Names: List 87

WHO Drug Information Vol. 16, No. 2, 2002

WHO Drug Information

is now available at:

http://www.who.int/druginformation